HPV Serum Level and FDG PET CT in Patients With Cervical Cancer Treated With Radical Radiochemotherapy

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

May 31, 2022

Study Completion Date

June 30, 2024

Conditions
Cervical Cancer
Interventions
DIAGNOSTIC_TEST

HPV serum level and FDG PET CT in patients with cervical cancer treated with radical radiochemotherapy

"Locally advanced non-operable newly diagnosed FIGO stage IB-IVA cervical cancer patients planned for definitive radiochemotherapy will be accrued to study and will have:~1. FDG PET Scan before treatment and 3 months after treatment~2. Pre- treatment DNA from the neoplastic time preserved in the form of paraffin blocks to determine HPV status~3. Blood sample to measure HPV DNA at time point baseline (before treatment), in the middle of treatment and at the end of definitive radiochemotherapy,~4. \[F-18\] - FDG PET scan before treatment and 3 months post completion of radiochemotherapy."

Trial Locations (1)

61-866

Greater Poland Cancer Centre / Oncological Gynecology Clinic, Poznan

All Listed Sponsors
lead

The Greater Poland Cancer Centre

OTHER